FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.
What happened
FDA reviewed the company's website ong tien linh chi.com in April 2026 and read the product labels. FDA also tried to buy "Sâm Xương Khớp Tế Bào Gốc Linh Chi Ông Tiên" from the site but received a product labeled "Sâm Xương Khớp Ông Tiên" instead. Lab testing of that product found piroxicam (an NSAID pain reliever) and dexamethasone phosphate (a steroid) that were not listed on the label.
What FDA found
The website and labels claim the products treat gout, arthritis, joint and back pain, inflammation, and even cancer, which makes them drugs under the law.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)The products are not generally recognized as safe and effective for those uses, and FDA has approved no application for them, so they are unapproved new drugs.
Sections 201(p) and 505(a) of the FD&C Act, 21 U.S.C. 321(p) and 355(a)The label for "Sâm Xương Khớp Ông Tiên" does not say it contains piroxicam or dexamethasone phosphate, so the labeling is false or misleading.
Section 502(a) of the FD&C Act, 21 U.S.C. 352(a)Shipping these unapproved and misbranded drugs across state lines is a prohibited act.
Sections 301(a) and 301(d) of the FD&C Act, 21 U.S.C. 331(a) and 331(d)
What FDA wants
FDA tells the company to find the root causes, fix the violations, and send a written response with the steps taken and supporting documents to FDAAdvisory@fda.hhs.gov within 15 business days, citing reference number 737352.
Who should pay attention
- online sellers and marketplaces listing imported herbal pain products
- importers and distributors of Vietnamese or Chinese herbal supplements
- consumers or clinics using herbal joint and arthritis remedies bought online
This is a summary. Read the original letter on fda.gov.